Faculty

Institution

Unit

Venue

Ayad A. Jaffa

Medical University of South Carolina

Affiliations

Research at the Medical University of South Carolina

NoneAyad A. Jaffa is currently serving as a Research At The Medical University Of South Carolina faculty at Medical University of South Carolina.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ayad A. Jaffa

Medical University of South Carolina

You can click a keyword to filter the displayed items

physiology pharmacology vascular biology nephrology renal function cell biology cell signaling molecular physiology diabetes renal pathophysiology diabetes research receptors signal transduction vascular pharmacology circulatory physiology urology diabetic medicine cellular physiology inflammation cardiovascular research chronic kidney disease diabetes therapies diabetic kidney disease hematology insulin signaling receptor (biochemistry) signaling pathways cellular biochemistry clinical biochemistry endothelial dysfunction medicinal research pharmacological research free radical biology protein phosphorylation diabetes mellitus enzyme inhibition receptor tyrosine kinases angiogenesis lipoprotein metabolism reactive oxygen species vascular cells clinical proteomics liver physiology metabolic regulation redox signaling renal kallikrein mesangial cells plasma prekallikrein cardiovascular physiology endocrine research kidney research g protein-coupled receptor clinical evidence dietary protein cytokines cardiovascular function human physiology vascular disease angiology vascular adaptation acute kidney injury protein secretion myocardial infarction wound care growth hormone renal bradykinin low-density lipoprotein-induced expression renin gene expression diabetic rat linear mixed models kallikrein-kinin system potential biomarkers renin-angiotensin system urinary pge2 mapk activation increased nitric oxide growth factor proteomics endocrinology proteome research

Notable Scholarly Works

Notable Federal Grants

Collaborators

Diabetes and the Social, Biologic, and Behavioral Determinants of Endometrial Cancer in the United States. Obstetrical & Gynecological Survey (2025)

medical sociologyunited statesbehavioral determinantsgynecologic oncologyendometrial cancercancer carefamily medicinegynecologic cancerssocial determinants of healthgynecologycancer disparitieswomen's health

The Impact of Diabetes and Social, Biologic and Behavioral Determinants of Health on Liver Cancer Risk. Frontiers in Endocrinology (2025)

health policybehavioral determinantsepidemiology of cancerchronic diseasesdiabetes researchpublic healthcancer careliver cancer risksocial determinants of healthliver disease

Development of Alginate and Alginate Sulfate/Polycaprolactone Nanoparticles for Growth Factor Delivery in Wound Healing Therapy. Biomedicine & Pharmacotherapy (2024)

nanoparticle researchbiomaterials designsulfate/polycaprolactone nanoparticlescontrolled releasewound carewound healing therapydrug deliverybiopolymersbiomedical engineeringgrowth factor deliverywound healingbiological engineering

Oxidative Stress and Cardiovascular Disease: Implication of Gender and Age. Oxidative stress in applied basic research and clinical practice (2024)

experimental gerontologyvascular aginghealth sciencesageingcardiovascular researchpreventive cardiologyoxidative stressstress (biology)free radical biologydyslipidemiaaging cellcardiovascular diseasephysiologylipid peroxidationwomen's health

Role of Insulin Use and Social Determinants of Health on Non-Melanoma Skin Cancer: Results From the Behavioral Risk Factor Surveillance System. Cancer Control (2024)

preventive medicinehealth policycancer preventionnon-melanoma skin cancerinsulin usesocial determinantspublic healthcancer careskin cancersocial determinants of healthbehavior change (public health)

Social and Racial Inequalities in Diabetes and Cancer in the United States. Frontiers in Public Health (2023)

social epidemiologydiabetes carehealth equityethnic studiesmedical sociologyhealth policyhealth care disparitieshealth disparitiesraceracial inequalitiessocial determinants of healthdiabetes researchsocial science researchdisparitiesracial discriminationunited statespublic healthhealth inequalitiescancer disparities

Polymeric Nanoparticles in the Diagnosis and Treatment of Myocardial Infarction: Challenges and Future Prospects. Materials Today Bio (2022)

nanoparticle researchpharmaceutical nanotechnologynanomedicinenanoparticlesfuture prospectspolymer nanotechnologytherapeutic nanomaterialscontrolled releasemyocardial infarctionpolymeric nanoparticlesbiopolymersbiomedical engineeringpolymer sciencebiological engineering

Modulation of Neuro-Inflammatory Signals in Microglia by Plasma Prekallikrein and Neuronal Cell Debris. Frontiers in Pharmacology (2021)

Aneese A. JaffaMiran A. JaffaMayssam MoussaIbrahim A. AhmedMia KaramKawthar Sharaf AldeenRola Al SayeghGhewa A. El-AchkarLeila NasrallahYara YehyaAida HabibFuad N. ZiyadehAli H. EidFiras H. KobeissyAyad A. Jaffa

pharmacologyinflammationplasma prekallikreinneuro-inflammatory signalsneuroscienceneuronal cell debrisneuroinflammationneuroimmunology

Overcoming Pd-1 Inhibitor Resistance With a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma. Cancers (2021)

Patrick NasarreDenise I. GarciaJulie B. SiegelIngrid V. BonillaRupak MukherjeeEleanor HilliardParamita ChakrabortyCécile NasarreJason T. YusteinMargaret LangAneese A. JaffaShikhar MehrotraNancy Klauber-DeMore

tumor targetingdrug resistancetherapy resistancemonoclonal antibodycancer cellsmetastatic osteosarcomacancer biologycancer researchmetastasisbiomarker targetpharmacologyoncologyimmunologyoncogenesenzyme inhibitionmolecular biologymedicinal researchnovel therapiestherapeutic targets

Plasma Kallikrein as a Modulator of Liver Injury/Remodeling. Frontiers in Pharmacology (2021)

Ibrahim A AhmedMiran A JaffaMayssam MoussaDuaa HatemGhewa A El-AchkarRola Al SayeghMia KaramEva HamadeAida HabibAyad A Jaffa

pharmacological researchpharmacologyinflammationplasma kallikreindrug-induced liver injuryexperimental pharmacology

1
2
3
4
5
12
10 / page

Ayad A. Jaffa

Medical University of South Carolina

Affiliations

Research at the Medical University of South Carolina

NoneAyad A. Jaffa is currently serving as a Research At The Medical University Of South Carolina faculty at Medical University of South Carolina.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ayad A. Jaffa

Medical University of South Carolina

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Diabetes and the Social, Biologic, and Behavioral Determinants of Endometrial Cancer in the United States. Obstetrical & Gynecological Survey (2025)

The Impact of Diabetes and Social, Biologic and Behavioral Determinants of Health on Liver Cancer Risk. Frontiers in Endocrinology (2025)

health policybehavioral determinantsepidemiology of cancerchronic diseasesdiabetes researchpublic healthcancer careliver cancer risksocial determinants of healthliver disease

Development of Alginate and Alginate Sulfate/Polycaprolactone Nanoparticles for Growth Factor Delivery in Wound Healing Therapy. Biomedicine & Pharmacotherapy (2024)

Oxidative Stress and Cardiovascular Disease: Implication of Gender and Age. Oxidative stress in applied basic research and clinical practice (2024)

Role of Insulin Use and Social Determinants of Health on Non-Melanoma Skin Cancer: Results From the Behavioral Risk Factor Surveillance System. Cancer Control (2024)

preventive medicinehealth policycancer preventionnon-melanoma skin cancerinsulin usesocial determinantspublic healthcancer careskin cancersocial determinants of healthbehavior change (public health)

Social and Racial Inequalities in Diabetes and Cancer in the United States. Frontiers in Public Health (2023)

Polymeric Nanoparticles in the Diagnosis and Treatment of Myocardial Infarction: Challenges and Future Prospects. Materials Today Bio (2022)

Modulation of Neuro-Inflammatory Signals in Microglia by Plasma Prekallikrein and Neuronal Cell Debris. Frontiers in Pharmacology (2021)

pharmacologyinflammationplasma prekallikreinneuro-inflammatory signalsneuroscienceneuronal cell debrisneuroinflammationneuroimmunology

Overcoming Pd-1 Inhibitor Resistance With a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma. Cancers (2021)

Plasma Kallikrein as a Modulator of Liver Injury/Remodeling. Frontiers in Pharmacology (2021)

Ibrahim A AhmedMiran A JaffaMayssam MoussaDuaa HatemGhewa A El-AchkarRola Al SayeghMia KaramEva HamadeAida HabibAyad A Jaffa

pharmacological researchpharmacologyinflammationplasma kallikreindrug-induced liver injuryexperimental pharmacology

1
2
3
4
5
12
10 / page

Similar Faculty Members

Jerry Nadler

Institution

Eastern Virginia Medical School

diabetes

immunology

Perry V. Halushka

Institution

Medical University of South Carolina

molecular characterization

disease pathophysiology

Yi Tan

Institution

University of Louisville

metabolic disorder

health science

Kumar Sharma

Institution

University of Texas Health Science Center at San Antonio

nephrology

chronic kidney disease

William E Mitch

Institution

Baylor College of Medicine

molecular metabolism

energy metabolism

Shahid Baba

Institution

University of Louisville

pharmacology

physiology

Yiliang Chen

Institution

Medical College of Wisconsin

omics

biomarker

Sudhir Shah

Institution

University of Arkansas for Medical Sciences

health science

free radical biology

Thomas Myron Coffman

Institution

Duke University

nephrology

pharmacology

Qing Robert Miao

Institution

New York University

epigenetics

obesity

Similar Faculty Members

Jerry Nadler

Institution

Eastern Virginia Medical School

diabetes

immunology

Perry V. Halushka

Institution

Medical University of South Carolina

molecular characterization

disease pathophysiology

Yi Tan

Institution

University of Louisville

metabolic disorder

health science

Kumar Sharma

Institution

University of Texas Health Science Center at San Antonio

nephrology

chronic kidney disease

William E Mitch

Institution

Baylor College of Medicine

molecular metabolism

energy metabolism

Shahid Baba

Institution

University of Louisville

pharmacology

physiology

Yiliang Chen

Institution

Medical College of Wisconsin

omics

biomarker

Sudhir Shah

Institution

University of Arkansas for Medical Sciences

health science

free radical biology

Thomas Myron Coffman

Institution

Duke University

nephrology

pharmacology

Qing Robert Miao

Institution

New York University

epigenetics

obesity